Reuters logo
BRIEF-FIT Biotech decided on issue of convertible notes and warrants
October 14, 2016 / 2:57 PM / a year ago

BRIEF-FIT Biotech decided on issue of convertible notes and warrants

Oct 14 (Reuters) - FIT Biotech Oy :

* Says has decided on issue of convertible notes and warrants

* On Aug. 25 decided to establish Convertible Note and Warrant Programmes in order to implement Convertible Notes with Warrants Funding Programme of up to 12,480,000 euros ($13.98 million) between Fit Biotech and Sitra

* Says has decided to withdraw second tranche of 250,000 euros included in program and to issue to Sitra total of 250 convertible notes and 884,643 warrants Source text for Eikon: Further company coverage: ($1 = 0.8928 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below